Table 4.

NK-cell development from LinSP cells

ConditionCD7+LinSPCD34+Lin SP
Fold-expansion
(range)
% CD56+
(range)
% CD56+ CD94+
(range)
Fold-expansion
(range)
% CD56+
(range)
% CD56+ CD94+
(range)
4.3 ± 5.8 74.9 ± 19 25.1 ± 6.5 14.8 ± 17 68.4 ± 12 45.6 ± 8.3 
 (0.1-13) (53-87)4-150 (18-29)4-150 (0.1-35) (55-78)4-150 (40-55)4-150 
7.6 ± 11 55.9 ± 34 4-151 47.3 ± 67 5.1 ± 7.9 4-151 
 (1.6-25) (8.2-86)  (3.5-145) (0.3-17)  
9.3 ± 7.0 91.0 ± 10 5.2 ± 6.7 2.8 ± 0.9 9.5 ± 13 4.2 ± 7.7 
 (1.6-17) (76-99) (0-15) (1.5-3.4) (1.4-29) (0-16) 
20 ± 28 85.8 ± 16 28.1 ± 23 35.9 ± 74 34 ± 41 14 ± 25 
 (4.4-68)4-153 (62-96.8) (4-41) (1.4-168)4-153 (0.9-86)4-155 (0.3-52) 
ConditionCD7+LinSPCD34+Lin SP
Fold-expansion
(range)
% CD56+
(range)
% CD56+ CD94+
(range)
Fold-expansion
(range)
% CD56+
(range)
% CD56+ CD94+
(range)
4.3 ± 5.8 74.9 ± 19 25.1 ± 6.5 14.8 ± 17 68.4 ± 12 45.6 ± 8.3 
 (0.1-13) (53-87)4-150 (18-29)4-150 (0.1-35) (55-78)4-150 (40-55)4-150 
7.6 ± 11 55.9 ± 34 4-151 47.3 ± 67 5.1 ± 7.9 4-151 
 (1.6-25) (8.2-86)  (3.5-145) (0.3-17)  
9.3 ± 7.0 91.0 ± 10 5.2 ± 6.7 2.8 ± 0.9 9.5 ± 13 4.2 ± 7.7 
 (1.6-17) (76-99) (0-15) (1.5-3.4) (1.4-29) (0-16) 
20 ± 28 85.8 ± 16 28.1 ± 23 35.9 ± 74 34 ± 41 14 ± 25 
 (4.4-68)4-153 (62-96.8) (4-41) (1.4-168)4-153 (0.9-86)4-155 (0.3-52) 

One hundred to 2000 CD7+Lin SP cells or CD34+Lin SP cells were cultured on MS5 stroma under the culture conditions defined in Table 1. The expansions and percentages of CD56+ or CD56+ CD94+progeny of CD7+Lin SP or CD34+Lin SP cells were derived from the total CD45+ cells present in the immunophenotyping studies. The data are the mean and SD of 4 (conditions A, B, and C) or 6 (condition D) separate experiments.

SP indicates side population.

F4-150

One of 4 cultures failed to generate CD56+ progeny.

F4-151

Too few CD56+ cells were elicited for an accurate determination.

P ≤ .05 for differences between the values for CD7+Lin SP and CD34+Lin SP.

F4-153

Data are derived from 4 of 6 cultures with expansion.

F4-155

Two of 4 cultures with expansion failed to generate CD56+ progeny.

or Create an Account

Close Modal
Close Modal